Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
株式のランク
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
株価
$3.40
時価総額
$9.07B
変化（1日）
-1.61%
変化（1年）
-16.08%
国
CN
取引 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
カテゴリー
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の営業利益率
2026 時点の営業利益率 TTM: 0.00%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 0.00% です。2026 年末時点では 0.00% でした。
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の営業利益率の履歴（2001 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2025 | 6.08% | -41.20% |
| 2024 | 10.34% | 29.41% |
| 2023 | 7.99% | -24.55% |
| 2022 | 10.59% | -34.47% |
| 2021 | 16.16% | 3.72% |
| 2020 | 15.58% | -0.89% |
| 2019 | 15.72% | 10.78% |
| 2018 | 14.19% | -35.47% |
| 2017 | 21.99% | -5.22% |
| 2016 | 23.20% | -11.28% |
| 2015 | 26.15% | 31.34% |
| 2014 | 19.91% | 84.69% |
| 2013 | 10.78% | 33.25% |
| 2012 | 8.09% | -66.80% |
| 2011 | 24.37% | -2.68% |
| 2010 | 25.04% | 422.76% |
| 2009 | 4.79% | 29.81% |
| 2008 | 3.69% | -81.50% |
| 2007 | 19.95% | 142.11% |
| 2006 | 8.24% | 4.97% |
| 2005 | 7.85% | 64.92% |
| 2004 | 4.76% | -68.41% |
| 2003 | 15.07% | -7.72% |
| 2002 | 16.33% | -17.48% |
| 2001 | 19.79% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | - |
IN
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。